Showing results (221-230 of 357) with videos related to
Sort By:
Pageof 36
Cancer Biology & Therapy|July 25, 2006
Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cellsJorge G Gomez-Gutierrez, Vinicius Souza, Hong Ying Hao, et al.Cancers|May 19, 2019
Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic VirotherapyNadiia Lypova, Lilibeth Lanceta, Alana Gibson, et al.Surgery|August 4, 2018
The impact of enhanced recovery pathways on cost of care and perioperative outcomes in patients undergoing gastroesophageal and hepatopancreatobiliary surgeryNeal Bhutiani, Seth A Quinn, Jordan M Jones, et al.The American Surgeon|January 16, 2013
Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancerRobert M Cannon, Russell E Brown, Charles R St Hill, et al.Aging|December 29, 2020
Age-related transcriptome changes in melanoma patients with tumor-positive sentinel lymph nodesDerek S Menefee, Austin McMasters, Jianmin Pan, et al.The American Surgeon|July 3, 2013
Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patientsNicolas P Burnett, Erik M Dunki-Jacobs, Glenda G Callender, et al.Cancers|May 19, 2018
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In VitroRodolfo Garza-Morales, Roxana Gonzalez-Ramos, Akiko Chiba, et al.Cancers|April 13, 2024
Correction: Garza-Morales et al. Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. <i>Cancers</i> 2018, <i>10</i>, 144Rodolfo Garza-Morales, Roxana Gonzalez-Ramos, Akiko Chiba, et al.Journal of the American College of Surgeons|February 3, 2020
Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease ExceptionRobert M Cannon, Eric G Davis, David S Goldberg, et al.Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.Pageof 36